According to SEC filings, Genvax Technologies, a company specializing in vaccines for animal health, has raised ~USD 3.4 million in equity financing backed by nine investors.
Analyst QuickTake: This funding round brings Genvax Technologies' total raised to ~USD 10 million. The company develops advanced mRNA and nanoparticle vaccines to counter the spreading variants of animal diseases.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.